Literature DB >> 23688547

Rotavirus genotype distribution during the pre-vaccine period in Bolivia: 2007-2008.

Rosario Rivera1, Kristen Forney, Maria René Castro, Paulina A Rebolledo, Nataniel Mamani, Maritza Patzi, Percy Halkyer, Juan S Leon, Volga Iñiguez.   

Abstract

OBJECTIVES: Rotavirus is the most important etiology of severe diarrhea in Bolivia. The monovalent attenuated human oral rotavirus vaccine Rotarix(®) was introduced in Bolivia in 2008. We describe the molecular epidemiology of circulating rotavirus strains before vaccine introduction.
METHODS: Two thousand one hundred thirty-five diarrheal samples were collected from hospitals in four Bolivian cities during 2007-2008. Forty-three percent (445 of 1030 rotavirus-positive samples) were analyzed for G and P genotypes. Among those, 331 were electropherotyped by polyacrylamide gel electrophoresis. Disease severity was quantified using a modified Vesikari scale.
RESULTS: Among the 445 samples, five genotypes were found to be prevalent: G9P[8] (33%), G1P[6] (17%), G2P[4] (13%), G9P[6] (12%), and G1P[8] (4%). Co-infections with two or more strains accounted for 14% of samples. The most prevalent strain, G9, showed greater electropherotype diversity compared to other serogroups. Strain G1P[6] generally infected younger children and peaked later in the year than other strains. No particular genotype was associated with a higher severity score, though there was a significant difference in the duration of diarrhea between genotypes.
CONCLUSIONS: During the 2-year pre-vaccine period, substantial diversity of rotavirus co-circulating strains was observed. These data constitute a baseline against which changes in circulating strains post-vaccine introduction can be monitored.
Copyright © 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Epidemiologic surveillance; Molecular epidemiology; Pediatric diarrhea; Pediatric infectious diseases; Rotavirus

Mesh:

Substances:

Year:  2013        PMID: 23688547      PMCID: PMC3782082          DOI: 10.1016/j.ijid.2013.03.016

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  33 in total

1.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

2.  Lack of maternal antibodies to P serotypes may predispose neonates to infections with unusual rotavirus strains.

Authors:  M Ramachandran; A Vij; R Kumar; B K Das; J R Gentsch; M K Bhan; R I Glass
Journal:  Clin Diagn Lab Immunol       Date:  1998-07

3.  Incidence of severe rotavirus diarrhea in New Delhi, India, and G and P types of the infecting rotavirus strains.

Authors:  Rajiv Bahl; Pratima Ray; Swati Subodh; Prashant Shambharkar; Manju Saxena; Umesh Parashar; Jon Gentsch; Roger Glass; M K Bhan
Journal:  J Infect Dis       Date:  2005-09-01       Impact factor: 5.226

4.  Characterization of rotavirus strains from newborns in New Delhi, India.

Authors:  B K Das; J R Gentsch; H G Cicirello; P A Woods; A Gupta; M Ramachandran; R Kumar; M K Bhan; R I Glass
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

5.  Independent segregation of two antigenic specificities (VP3 and VP7) involved in neutralization of rotavirus infectivity.

Authors:  Y Hoshino; M M Sereno; K Midthun; J Flores; A Z Kapikian; R M Chanock
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

Review 6.  The epidemiology of rotavirus diarrhea in Latin America. Anticipating rotavirus vaccines.

Authors:  Erin M Kane; Reina M Turcios; Melissa L Arvay; Salvador Garcia; Joseph S Bresee; Roger I Glass
Journal:  Rev Panam Salud Publica       Date:  2004-12

Review 7.  Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine.

Authors:  Norma Santos; Yasutaka Hoshino
Journal:  Rev Med Virol       Date:  2005 Jan-Feb       Impact factor: 6.989

8.  Rotavirus diarrhea in Bangladeshi children: correlation of disease severity with serotypes.

Authors:  C Bern; L Unicomb; J R Gentsch; N Banul; M Yunus; R B Sack; R I Glass
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

9.  Identification of group A rotavirus gene 4 types by polymerase chain reaction.

Authors:  J R Gentsch; R I Glass; P Woods; V Gouvea; M Gorziglia; J Flores; B K Das; M K Bhan
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

Review 10.  Oral rotavirus vaccines: how well will they work where they are needed most?

Authors:  Manish Patel; Andi L Shane; Umesh D Parashar; Baoming Jiang; Jon R Gentsch; Roger I Glass
Journal:  J Infect Dis       Date:  2009-11-01       Impact factor: 5.226

View more
  4 in total

1.  Genotypic Distribution of Rotavirus in Phnom Penh, Cambodia: An Association of G9 with More Severe Diseases.

Authors:  Sasikorn Silapong; Pimmada Sakpaisal; Ladaporn Bodhidatta; Paphavee Lertsethtakarn; Orntipa Sethabutr; Ket Vansith; Chhour Y Meng; Brett E Swierczewski; Carl J Mason
Journal:  Am J Trop Med Hyg       Date:  2017-02-06       Impact factor: 2.345

2.  Risk factors for diarrhea in children under five years of age residing in peri-urban communities in Cochabamba, Bolivia.

Authors:  Christine Marie George; Jamie Perin; Karen J Neiswender de Calani; W Ray Norman; Henry Perry; Thomas P Davis; Erik D Lindquist
Journal:  Am J Trop Med Hyg       Date:  2014-10-13       Impact factor: 2.345

Review 3.  Review of global rotavirus strain prevalence data from six years post vaccine licensure surveillance: is there evidence of strain selection from vaccine pressure?

Authors:  Renáta Dóró; Brigitta László; Vito Martella; Eyal Leshem; Jon Gentsch; Umesh Parashar; Krisztián Bányai
Journal:  Infect Genet Evol       Date:  2014-09-16       Impact factor: 3.342

4.  Burden of Norovirus and Rotavirus in Children After Rotavirus Vaccine Introduction, Cochabamba, Bolivia.

Authors:  Casey L McAtee; Rachel Webman; Robert H Gilman; Carolina Mejia; Caryn Bern; Sonia Apaza; Susan Espetia; Mónica Pajuelo; Mayuko Saito; Roxanna Challappa; Richard Soria; Jose P Ribera; Daniel Lozano; Faustino Torrico
Journal:  Am J Trop Med Hyg       Date:  2015-11-23       Impact factor: 2.345

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.